Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Data Collection and Documentation

Posted on By

Protocol for Data Capture and Record-keeping in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the systematic collection, recording, and management of data generated during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry.

Scope

This SOP applies to all personnel involved in data collection, including Study Coordinators, Clinical Research Associates (CRAs), Laboratory Technicians, and Data Managers.

Responsibilities

  • The Study Coordinator is responsible for overseeing data collection activities, ensuring compliance with the study protocol and regulatory requirements.
  • The Clinical Research Associate (CRA) is responsible for monitoring data collection procedures at the study site and verifying the accuracy and completeness of study records.
  • The Laboratory Technician is responsible for documenting analytical results, instrument readings, and sample handling procedures according to established protocols.
  • The Data Manager is responsible for maintaining study databases, organizing and archiving study documents, and ensuring data integrity and security.
See also  SOP for Drug Return and Destruction

Procedure

  1. Develop a data collection plan outlining the types of data to be collected, data sources, collection methods, and responsible personnel.
  2. Train study personnel on data collection procedures, including proper documentation techniques, data entry protocols, and confidentiality requirements.
  3. Collect data systematically and accurately using standardized data collection forms, electronic data capture systems, or laboratory notebooks.
  4. Record data promptly and legibly, ensuring that all entries
are dated, signed, and attributed to the appropriate source or personnel.
  • Review data for completeness, consistency, and accuracy, resolving any discrepancies or missing information promptly with the relevant study personnel.
  • Store and maintain study documents and data records in a secure and organized manner, following established procedures for document retention and archiving.
  • Ensure that data management procedures comply with regulatory requirements, including data privacy, confidentiality, and Good Clinical Practice (GCP) guidelines.
  • Regularly backup study databases and electronic records to prevent data loss or corruption, and implement appropriate access controls to protect sensitive information.
  • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • CRA – Clinical Research Associate
    • GCP – Good Clinical Practice

    Documents

    • Data Collection Plan
    • Data Collection Forms
    • Study Database
    • Data Management SOP

    Reference

    International Conference on Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory requirements for data collection and documentation in clinical trials.

    SOP Version

    Version 1.0

    See also  SOP for Study Design Planning
    Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

    Post navigation

    Previous Post: SOP for Analytical Run Setup and Conduct
    Next Post: SOP for Data Entry and Management

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version